World News

Retinopathy Risk With Long-Term HCQ Treatment Detailed in Meta-Analysis

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

Retinopathy Risk With Long-Term HCQ Treatment Detailed in Meta-Analysis (MedPage Today) — About one in 18 patients taking hydroxychloroquine (HCQ) for 15 years develop retinal damage, a new meta-analysis indicated.
With a total of some 20,000 patients in 19 included datasets, the 15-year cumulative incidence of retinopathy…

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button